Display options
Share it on

J Bone Metab. 2017 Aug;24(3):187-196. doi: 10.11005/jbm.2017.24.3.187. Epub 2017 Aug 31.

Quality of Life in Patients with Osteoporotic Vertebral Compression Fractures.

Journal of bone metabolism

Ho Jin Jung, Ye-Soo Park, Hyoung-Yeon Seo, Jae-Chul Lee, Ki-Chan An, Jin-Hyok Kim, Byung-Joon Shin, Tae Wook Kang, Si Young Park

Affiliations

  1. Department of Orthopaedic Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  2. Department of Orthopaedic Surgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  3. Department of Orthopaedic Surgery, Chonnam National University Hospital, Gwangju, Korea.
  4. Department of Orthopaedic Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
  5. Department of Orthopaedic Surgery, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  6. Department of Orthopaedic Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

PMID: 28955695 PMCID: PMC5613024 DOI: 10.11005/jbm.2017.24.3.187

Abstract

BACKGROUND: This study aimed to evaluate quality of life (QOL) using the EuroQOL-5 dimensions (EQ-5D) index and to examine factors affecting QOL in patients with an osteoporotic vertebral compression fracture (OVCF).

METHODS: This ambispective study used a questionnaire interview. Patients over 50 years old with an OVCF at least 6 months previously were enrolled. Individual results were used to calculate the EQ-5D index. Statistical analysis was performed, and factors related to QOL were examined.

RESULTS: Of 196 patients in the study, 84.2% were female, with an average age of 72.7 years. There were 66 (33.7%) patients with multilevel fractures. Conservative management was used in 75.0% of patients, and 56.1% received anti-osteoporosis treatment. The mean EQ-5D index was 0.737±0.221 and was significantly correlated with the Oswestry disability index score (correlation coefficient -0.807,

CONCLUSIONS: OVCF markedly lowers QOL in several dimensions for up to 12 months, even in patients who have healed. Treatment of osteoporosis and conservative treatment methods affect QOL and should be considered in OVCF management.

Keywords: Compression fractures; Osteoporosis; Quality of life

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

  1. N Engl J Med. 2016 Jan 21;374(3):254-62 - PubMed
  2. Spine J. 2012 Nov;12(11):998-1005 - PubMed
  3. Spine J. 2014 Sep 1;14(9):2063-77 - PubMed
  4. Bone. 1996 Mar;18(3 Suppl):185S-189S - PubMed
  5. Osteoporos Int. 1999;9(6):508-15 - PubMed
  6. Asian Spine J. 2013 Dec;7(4):301-7 - PubMed
  7. Climacteric. 2014 Feb;17(1):60-70 - PubMed
  8. Support Care Cancer. 2012 Dec;20(12):3155-60 - PubMed
  9. J Bone Miner Res. 2004 Aug;19(8):1241-9 - PubMed
  10. J Bone Miner Metab. 2012 Jan;30(1):54-8 - PubMed
  11. Osteoporos Int. 2012 Jul;23(7):1859-65 - PubMed
  12. Osteoporos Int. 2005 May;16(5):447-55 - PubMed
  13. Osteoporos Int. 1999;10(2):150-60 - PubMed
  14. Spine (Phila Pa 1976). 2014 Apr 15;39(8):678-82 - PubMed
  15. Spine (Phila Pa 1976). 2005 Mar 1;30(5):E123-7 - PubMed
  16. Osteoporos Int. 2004 Sep;15(9):760-5 - PubMed
  17. Eur Spine J. 2008 Oct;17(10):1380-90 - PubMed
  18. JAMA. 1999 Oct 13;282(14 ):1344-52 - PubMed
  19. N Engl J Med. 2009 Aug 6;361(6):557-68 - PubMed
  20. Asian Spine J. 2014 Oct;8(5):653-8 - PubMed
  21. J Bone Miner Metab. 2012 Mar;30(2):183-92 - PubMed
  22. Eur Spine J. 2012 Sep;21(9):1826-43 - PubMed
  23. JAMA. 2009 Feb 4;301(5):513-21 - PubMed
  24. Perm J. 2012 Fall;16(4):46-51 - PubMed
  25. Osteoporos Int. 1999;10(1):26-33 - PubMed
  26. Eur Spine J. 2009 Jan;18(1):77-88 - PubMed
  27. Osteoporos Int. 2016 Oct;27(10):2891-900 - PubMed
  28. Bone. 1992;13 Suppl 2:S27-31 - PubMed
  29. Eur Spine J. 2010 Apr;19(4):567-74 - PubMed
  30. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3100-3 - PubMed
  31. Osteoporos Int. 2004 Oct;15(10):834-41 - PubMed
  32. N Engl J Med. 2009 Aug 6;361(6):569-79 - PubMed
  33. Spine (Phila Pa 1976). 2013 Apr 20;38(9):757-61 - PubMed
  34. Am J Med. 1997 Aug 18;103(2A):12S-17S; discussion 17S-19S - PubMed
  35. Clin Rheumatol. 1989 Jun;8 Suppl 2:66-9 - PubMed
  36. Diabetes Metab J. 2011 Dec;35(6):587-94 - PubMed
  37. Calcif Tissue Int. 1991;49 Suppl 2:S9-13 - PubMed
  38. Lancet. 1996 Dec 7;348(9041):1535-41 - PubMed
  39. Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):671-85 - PubMed
  40. JAMA. 2001 Feb 14;285(6):785-95 - PubMed
  41. J Bone Miner Res. 1996 Jul;11(7):1026-32 - PubMed
  42. Calcif Tissue Int. 2005 Apr;76(4):235-42 - PubMed
  43. Osteoporos Int. 2000;11(1):83-91 - PubMed
  44. JAMA. 1998 Dec 23-30;280(24):2077-82 - PubMed
  45. Maturitas. 2010 Jun;66(2):206-11 - PubMed
  46. Value Health. 2009 Nov-Dec;12(8):1187-93 - PubMed
  47. Ann Rheum Dis. 2000 May;59(5):368-71 - PubMed
  48. Int J Technol Assess Health Care. 2006 Spring;22(2):235-41 - PubMed
  49. Health Qual Life Outcomes. 2014 Apr 24;12:57 - PubMed
  50. Lancet. 2009 Mar 21;373(9668):1016-24 - PubMed
  51. Lancet. 2010 Sep 25;376(9746):1085-92 - PubMed
  52. Qual Life Res. 2005 Jun;14(5):1401-6 - PubMed

Publication Types